|
NDC80 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.28894680986969E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.048900E-04 |
| Normal-vs-Stage2 |
6.242400E-02 |
| Normal-vs-Stage3 |
1.826600E-04 |
| Normal-vs-Stage4 |
1.162380E-02 |
| Stage1-vs-Stage2 |
6.026000E-01 |
| Stage1-vs-Stage3 |
8.240800E-03 |
| Stage1-vs-Stage4 |
5.456100E-02 |
| Stage2-vs-Stage3 |
8.882500E-02 |
| Stage2-vs-Stage4 |
2.188200E-01 |
| Stage3-vs-Stage4 |
7.868200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.297100037436E-09 |
| Normal-vs-AfricanAmerican |
5.616100E-04 |
| Normal-vs-Asian |
3.204200E-02 |
| Caucasian-vs-AfricanAmerican |
8.031000E-01 |
| Caucasian-vs-Asian |
2.211400E-01 |
| AfricanAmerican-vs-Asian |
1.403240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.89535062591995E-12 |
| Normal-vs-Female |
2.974900E-04 |
| Male-vs-Female |
1.246400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.243400E-04 |
| Normal-vs-Extreme_Weight |
3.33390000051281E-07 |
| Normal-vs-Obese |
1.90212999999773E-05 |
| Normal-vs-Extreme_Obese |
1.192160E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.531360E-01 |
| Normal_Weight-vs-Obese |
8.867400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.367710E-02 |
| Extreme_Weight-vs-Obese |
1.057580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.786500E-02 |
| Obese-vs-Extreme_Obese |
4.301100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.300100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.78220005420116E-09 |
| Normal-vs-Age(61-80Yrs) |
1.000610E-04 |
| Normal-vs-Age(81-100Yrs) |
6.106500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.203810E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.164000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.429700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.354600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.331200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.088200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.5443994667902E-10 |
| Normal-VS-Type2 PRCC |
2.28449999999381E-05 |
| Normal-VS-KIRP CIMP |
2.696700E-03 |
| Normal-VS-Unclassified PRCC |
7.790700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.186000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.275300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.291800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.509830E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.264400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.096330E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.399200E-04 |
| Normal-vs-N1 |
3.61660000003372E-06 |
| Normal-vs-N2 |
6.467700E-02 |
| N0-vs-N1 |
4.594100E-04 |
| N0-vs-N2 |
6.530800E-01 |
| N1-vs-N2 |
1.639020E-01 |
|
|
